A study showed that an investigational drug, idarucizumab, reverses the anticoagulant effect of dabigatran, a blood thinning drug used for the prevention of stroke. This is the first test of this reversal agent in patients with bleeding or need for emergent surgery.
Author: Sarah Plumridge
Rebecca Edwards, an MD/PhD student, studies the role host factors play in mediating disease in the eye caused by the herpes simplex virus type 1.
Feinberg faculty have received a National Institutes of Health grant to develop a statistical framework for correcting measurement errors associated with self-reported diet assessment.
A new Northwestern Medicine research center funded by the American Heart Association will study links between dietary phosphate and heart disease, with a focus on reducing health disparities in minority populations.
Supriya Rastogi, a second-year MD/MPH student, received a Schweitzer Fellowship to conduct a year-long project aimed at tackling racial and ethnic health disparities, with a focus on reproductive health on the South Side of Chicago.
Jonathan Licht, MD, Johanna Dobe Professor and chief of the Division of Medicine-Hematology/Oncology, has accepted a new leadership position at the University of Florida Health Cancer Center.
A study coauthored by Northwestern Medicine scientists found that normal cells stop proliferating when they lose important intracellular structures called centrioles, but cancer cells continue to multiply.
Peng Ji, MD, PhD, ’13 GME assistant professor in Pathology, was recently honored with one of the American Society of Clinical Investigation’s (ASCI) 2015 Young Physician-Scientist Awards
Emergency room visits and hospitalizations for severe allergic reactions climbed 29 percent per year over 5 years, according to a new Northwestern Medicine study.
New research explores the causes of stillbirth by identifying genetic variations in tissue from archived samples, with the goal of identifying biomarkers that may be used in the future for prevention.